TCF12 Knockout HCT 116 Cell Line
Cat.No.:
EDC08350
Species:
Human
Cell Name:
HCT 116
Gene:
TCF12
Gene ID:
6938
Size:
1×10⁶cells
TCF12 Knockout Cell Line (HCT116) is an exclusive upgraded CRISPR/Cas9 system-mediated gene knockout cell, with the advantages of Optimized Strategy Design, Efficient Cell Transfection, High-Performance Cas9 Protein and Hassle-Free Cell Selection.
| Cat.No. | EDC08350 |
|---|---|
| Product Name | TCF12 Knockout HCT 116 Cell Line |
| Cell Line | HCT 116 |
| Cellosaurus ID | CVCL_0291 |
| Cell Line Synonyms | HCT-116, HCT.116, HCT_116, HCT116, HCT116wt, HCT-116/P, HCT-116/parental, CoCL2 |
| Gene | TCF12 |
| NCBI Gene ID | |
| Gene Synonyms | CRS3|HEB|HH26|HTF4|HsT17266|TCF-12|bHLHb20|p64 |
| Summary |
The protein encoded by this gene is a member of the basic helix-loop-helix (bHLH) E-protein family that recognizes the consensus binding site (E-box) CANNTG. This encoded protein is expressed in many tissues, among them skeletal muscle, thymus, B- and T-cells, and may participate in regulating lineage-specific gene expression through the formation of heterodimers with other bHLH E-proteins. Several alternatively spliced transcript variants of this gene have been described, but the full-length nature of some of these variants has not been determined. [provided by RefSeq, Jul 2008]
|
| Associated Diseases | Colorectal Carcinoma |
| Morphology | Adherent |
| Passage Ratio | 1/5-1/4,2days |
| Complete Culture Medium | mcCoy5A+10%FBS |
| Freezing Medium | 90%FBS/Complete culture medium+10% DMSO |
| QC | Indels validated by Sanger sequencing; sterility confirmed via microbial testing. |
* For research use only. Not intended for use in humans or animals, including clinical, therapeutic, or diagnostic purposes.
| Loci | STR Info (Sample Cell) Sample Cell Line: HCT 116 | STR Info (Cell bank) Cell Line: HCT 116 | ||||||
| Allele1 | Allele2 | Allele3 | Allele4 | Allele1 | Allele2 | Allele3 | Allele4 | |
| Amelogenin | X | X | ||||||
| CSF1PO | 7 | 10 | 7 | 9 | 10 | 11 | ||
| D2S1338 | 16 | 16 | ||||||
| D3S1358 | 12 | 17 | 18 | 19 | 12 | 18 | 19 | |
| D5S818 | 10 | 11 | 10 | 11 | ||||
| D7S820 | 11 | 12 | 11 | 12 | ||||
| D8S1179 | 10 | 12 | 14 | 15 | 10 | 12 | 14 | 15 |
| D13S317 | 10 | 12 | 10 | 12 | ||||
| D16S539 | 11 | 13 | 11 | 12 | 13 | 14 | ||
| D18S51 | 16 | 17 | 16 | 17 | ||||
| D19S433 | 12 | 13 | 12 | |||||
| D21S11 | 29 | 30 | 29 | 30 | ||||
| FGA | 18 | 23 | 18 | 23 | ||||
| Penta D | 9 | 13 | 9 | 13 | ||||
| Penta E | 12 | 13 | 14 | 12 | 13 | 14 | ||
| TH01 | 8 | 9 | 8 | 9 | ||||
| TPOX | 8 | 8 | ||||||
| vWA | 17 | 21 | 22 | 23 | 17 | 21 | 22 | 23 |
| D6S1043 | 13 | |||||||
| D12S391 | 17 | 21 | 22 | |||||
| D2S441 | 11 | 12 | ||||||
* STR authentication data of this cell line matches with that of cell lines sourced from ATCC, DSMZ, JCRB, and RIKEN databases.
Conclusion: The STR identification of this cell is correct.
Conclusion: The STR identification of this cell is correct.
FAQ
Which is better for studying TCF12 function, TCF12 Knockout HCT 116 Cell Line or TCF12 overexpression HCT 116 Cell Line?
The choice depends on whether you are studying TCF12 (HEB) as a class I bHLH transcription factor or its emerging roles in colorectal cancer and stem cell biology. The Knockout line is appropriate for asking whether TCF12 is required for E-box-dependent gene regulation, dimerization with class II bHLH factors, or specific developmental gene programs. Overexpression is useful for testing whether elevated TCF12 is sufficient to alter dimerization partner availability or to drive specific transcriptional programs.
Important consideration: TCF12 shares substantial functional overlap with E2A (TCF3) and HEB-T variants — single TCF12 knockout may show modest phenotypes if paralog compensation occurs. The EDITGENE Knockout line in HCT 116 is particularly relevant for colorectal cancer research, where TCF12 has been implicated in EMT and metastasis. Rescue with wild-type, dimerization-deficient, or DNA-binding-deficient TCF12 is the standard approach for dissecting structural contributions to function.
What are the application scenarios for this model?
Primary applications:
• bHLH dimerization studies: co-immunoprecipitation analysis of TCF12 interactions with class II bHLH partners (MyoD family, E2A, others) and class V Id proteins.
• E-box binding: ChIP-qPCR or ChIP-seq for TCF12 occupancy at E-box-containing promoters in the absence of TCF12.
• EMT and metastasis: epithelial/mesenchymal marker analysis, migration, and invasion assays relevant to TCF12's reported colorectal cancer roles.
• Paralog compensation: E2A (TCF3) expression measurement to assess class I bHLH family redundancy.
EDITGENE recommends this model for researchers investigating class I bHLH transcription factors, colorectal cancer EMT, and bHLH-mediated gene regulation.
Is this TCF12 Knockout HCT 116 Cell Line compatible with overexpression rescue experiments?
Yes. TCF12 rescue experiments require attention to dimerization and DNA binding:
• Construct design: use a codon-modified TCF12 sequence with a small C-terminal tag (FLAG, HA). TCF12 has multiple alternative splice isoforms — choose the isoform appropriate to the experimental context.
• Dimerization-deficient rescue: bHLH domain mutations that disrupt heterodimerization with class II bHLH partners separate DNA-binding from partnership-dependent functions.
• DNA-binding-deficient rescue: basic region mutations abolish E-box binding while preserving dimerization, enabling structure-function dissection.
• Paralog considerations: E2A (TCF3) expression analysis in rescue cells helps interpret class I bHLH family redundancy.
HCT 116 transduces efficiently with lentivirus and supports stable rescue line generation; the MSI-high background should be considered in colorectal cancer context studies.
* Research Use Disclaimer: Content is generated from publicly available research data, bioinformatic resources, and computational analyses for research reference only.